ATE222954T1 - Verfahren zur herstellung von dem anaphase- fördernden komplex - Google Patents

Verfahren zur herstellung von dem anaphase- fördernden komplex

Info

Publication number: ATE222954T1
Authority: AT; Austria
Prior art keywords: cells; apc; human; producing; anaphase
Prior art date: 1996-11-14

Application number

AT97950165T

Other languages

English (en)

Inventor

Kim Nasmyth

Wolfgang Zachariae

Marta Galova

Original Assignee

Boehringer Ingelheim Int

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-11-14

Filing date

1997-11-11

Publication date

2002-09-15

1997-11-11 Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int

2002-09-15 Application granted granted Critical

2002-09-15 Publication of ATE222954T1 publication Critical patent/ATE222954T1/de

Links

102000005446 Anaphase-Promoting Complex-Cyclosome Human genes 0.000 title abstract 4
108010031677 Anaphase-Promoting Complex-Cyclosome Proteins 0.000 title abstract 4
238000004519 manufacturing process Methods 0.000 title 1
210000004027 cell Anatomy 0.000 abstract 2
101000924577 Homo sapiens Adenomatous polyposis coli protein Proteins 0.000 abstract 1
230000022131 cell cycle Effects 0.000 abstract 1
102000055691 human APC Human genes 0.000 abstract 1
210000005260 human cell Anatomy 0.000 abstract 1
230000002452 interceptive effect Effects 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
230000002062 proliferating effect Effects 0.000 abstract 1
238000007423 screening assay Methods 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1
210000005253 yeast cell Anatomy 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
- C07K14/395—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Mycology (AREA)
Toxicology (AREA)
Cell Biology (AREA)
Microbiology (AREA)
Zoology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Enzymes And Modification Thereof (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Investigating Or Analysing Biological Materials (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT97950165T 1996-11-14 1997-11-11 Verfahren zur herstellung von dem anaphase- fördernden komplex ATE222954T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP96118297A EP0843008A1 (de)	1996-11-14	1996-11-14	Verfahren zur Herstellung von dem Anaphase-fördernden Komplex
PCT/EP1997/006268 WO1998021326A2 (en)	1996-11-14	1997-11-11	Methods for producing the anaphase promoting complex

Publications (1)

Publication Number	Publication Date
ATE222954T1 true ATE222954T1 (de)	2002-09-15

Family

ID=8223398

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT97950165T ATE222954T1 (de)	1996-11-14	1997-11-11	Verfahren zur herstellung von dem anaphase- fördernden komplex

Country Status (9)

Country	Link
EP (2)	EP0843008A1 (de)
JP (1)	JP2001503987A (de)
AT (1)	ATE222954T1 (de)
CA (1)	CA2269099A1 (de)
DE (1)	DE69715034T2 (de)
DK (1)	DK0942978T3 (de)
ES (1)	ES2181042T3 (de)
PT (1)	PT942978E (de)
WO (1)	WO1998021326A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9727277D0 (en) *	1997-12-23	1998-02-25	Medical Res Council	Assay
US6979551B2 (en)	2000-04-03	2005-12-27	Rigel Pharmaceuticals, Inc.	Assays for identifying ubiquitin agents and for identifying agents that modify the activity of ubiquitin agents
US6740495B1 (en)	2000-04-03	2004-05-25	Rigel Pharmaceuticals, Inc.	Ubiquitin ligase assay
EP1167539A1 (de) *	2000-06-29	2002-01-02	Boehringer Ingelheim International GmbH	Verfahren zur Identifizierung von Verbindungen die das Anaphae-fördernde Komplex hemmen
US20020115056A1 (en) *	2000-12-26	2002-08-22	Goodlett David R.	Rapid and quantitative proteome analysis and related methods
GB0305796D0 (en)	2002-07-24	2003-04-16	Micromass Ltd	Method of mass spectrometry and a mass spectrometer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2071550A1 (en) *	1989-12-13	1991-06-14	C. G. Sahasrabuddhe	Growth arrest of proliferating cells by transglutaminase inhibitors

1996
- 1996-11-14 EP EP96118297A patent/EP0843008A1/de not_active Withdrawn
1997
- 1997-11-11 JP JP52216998A patent/JP2001503987A/ja not_active Abandoned
- 1997-11-11 AT AT97950165T patent/ATE222954T1/de not_active IP Right Cessation
- 1997-11-11 DE DE69715034T patent/DE69715034T2/de not_active Expired - Fee Related
- 1997-11-11 WO PCT/EP1997/006268 patent/WO1998021326A2/en not_active Ceased
- 1997-11-11 PT PT97950165T patent/PT942978E/pt unknown
- 1997-11-11 EP EP97950165A patent/EP0942978B1/de not_active Expired - Lifetime
- 1997-11-11 DK DK97950165T patent/DK0942978T3/da active
- 1997-11-11 CA CA002269099A patent/CA2269099A1/en not_active Abandoned
- 1997-11-11 ES ES97950165T patent/ES2181042T3/es not_active Expired - Lifetime

Also Published As

Publication number	Publication date
WO1998021326A3 (en)	1998-10-08
ES2181042T3 (es)	2003-02-16
JP2001503987A (ja)	2001-03-27
DK0942978T3 (da)	2002-12-02
EP0942978A2 (de)	1999-09-22
CA2269099A1 (en)	1998-05-22
DE69715034D1 (de)	2002-10-02
EP0843008A1 (de)	1998-05-20
WO1998021326A2 (en)	1998-05-22
PT942978E (pt)	2003-01-31
DE69715034T2 (de)	2003-03-13
EP0942978B1 (de)	2002-08-28

Similar Documents

Publication	Publication Date	Title
ATE372377T1 (de)	2007-09-15	Verwendung von nanoemulsionen zur bestimmung der biokompatibilität von lipophilen stoffen im zellkultur-test und dafür geeignete nanoemulsionen
DE69939945D1 (de)	2009-01-02	Verfahren zur isolierung von stammzellen
DE3686050D1 (de)	1992-08-20	Vorrichtung zur kultivierung von zellen in vitro.
DE3788026D1 (de)	1993-12-09	Verfahren und Vorrichtung zur Kultivierung von Zellen.
ATE432342T1 (de)	2009-06-15	Eine methode zum entwurf von alpha-amylase mutanten mit vorbestimmten eigenschaften
DE69417442D1 (de)	1999-04-29	Elektrochemische brennstoffzelle mit verwendung von luft als oxidant und kühlung
DE69417011D1 (de)	1999-04-15	Verfahren zur herstellung von kathoden komponenten und zu ihrer verwendung in elektrochemischen zellen
DE69414630D1 (de)	1998-12-24	Vorrichtung zur optischen Beleuchtung und Untersuchung von Defekten in Halbleiterscheiben und Solarzellen
DE3869969D1 (de)	1992-05-21	Versuchsmethode unter verwendung von partikeln mit assoziiertem, fluoreszierendem stoff.
DE3586159D1 (de)	1992-07-09	Zusammensetzung und verfahren zur differenzierung von weissen blutzellen.
DE3879082D1 (de)	1993-04-15	Modul und vorrichtung zur anreicherung von sauerstoff.
DE69717997D1 (de)	2003-01-30	Verfahren zur herstellung von trockenen pulverteilchen, pulver hergestellt durch dieses verfahren und eine elektrode und eine vorrichtung zur anwendung in diesem verfahren
EE9700133A (et)	1997-12-15	Meetod imetaja reproduktiivtrakti rakkude karakteristikute muutmiseks, selleks kasutatav kompositsioon, selle valmistamise meetod ja kasutamine
DE69434497D1 (de)	2006-02-09	Verwendung von alpha-1,4-glukanlyase zur herstellung von 1,5 d-anhydrofruktose
DE68903576D1 (de)	1993-01-07	Signalpeptide, die in hefe wirksam sind und ihre verwendung zur sekretorischen expression von heterologen proteinen.
ATE78697T1 (de)	1992-08-15	Kombination von angiotensin- converting-enzymehemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln.
DE69715034D1 (de)	2002-10-02	Verfahren zur herstellung von dem anaphase-fördernden komplex
ES2062018T3 (es)	1994-12-16	Nuevos tintes de xanteno.
DE69033080D1 (de)	1999-06-02	Zuwachsfaktorrezeptorgen deriviert von platten des typs oc
DE3864512D1 (de)	1991-10-02	Verfahren zur herstellung von kandis mit gepressten gaszellen.
PT87809A (pt)	1989-05-31	Promotoren zur expression von freemd-dna in methylotrophen bakterien deren gewinnung und deren verwendung
EP0660422A3 (de)	1997-02-05	Verfahren und Gerät zur Herstellung von photovoltaischen Zellen.
ATE196165T1 (de)	2000-09-15	Methoden zur herstellung von protein c
DE58904672D1 (de)	1993-07-22	Verfahren zur herstellung einer festphasenmatrix.
DE3888887D1 (de)	1994-05-11	Monoklonale Antikörper gegen E7-Protein des Humanen Papillomvirus Typ 16, Verfahren zu ihrer Herstellung sowie ihre Verwendung.

Legal Events

Date

Code

Title

Description

2003-03-15

UEP

Publication of translation of european patent specification

Ref document number: 0942978

Country of ref document: EP

2007-08-15

REN

Ceased due to non-payment of the annual fee